ClinicalTrials.govpublic full text
A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
carcinoma, pancreas, pancreatic, antisense, oligonucleotide, gemcitabine, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 897722
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.